UNITY-CLL: U2 significantly improved progression-free survival over obinutuzumab plus chlorambucil (HR=0.54, p
TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting
On 6ix: 6ix.com/news/tg-therapeutics-announces-pivotal-data-from-the-unity-cll-and-unity-nhl-clinical
Story so far
- TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
- TG Therapeutics Highlights Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
- TG Therapeutics Announces Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
Earlier from TG Therapeutics
- TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
- TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib in Patients with Chronic Lymphocytic Leukemia Who Are Intolerant to Prior BTK or PI3K Inhibitor Therapy in Blood
- TG Therapeutics Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration for Ublituximab in Combination with Umbralisib as a Treatment for Patients with Chronic Lymphocytic Leukemia
- TG Therapeutics to Participate in the 3rd Annual Evercore ISI HealthCONx Conference
- TG Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
Later from TG Therapeutics
- TG Therapeutics Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple Sclerosis
- TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
- TG Therapeutics Announces Proposed Public Offering of Common Stock
- TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
- TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference
Follow TG Therapeutics into a list and get an email when it puts out news.
Follow TG Therapeutics